Similar articles

• Amplatzer occluder versus CardioSEAL/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect.

  Li Y, Zhou K, Hua Y, Wang C, Xie L, Fang J, Rong X, Shen J. Li Y, et al. Cardiol Young. 2013 Aug;23(4):582-96. doi: 10.1017/S1047951112001424. Epub 2012 Dec 3. Cardiol Young. 2013. PMID: 23199453
• Patent Foramen Ovale and Atrial Septal Defect: Utility of Alternative Imaging Modalities for the Diagnosis of Patent Foramen Ovale and Atrial Septal Defect.

  Mojadidi MK, Tobis JM. Mojadidi MK, et al. Echocardiography. 2015 Sep;32(9):1451-2. doi: 10.1111/echo.13021. Echocardiography. 2015. PMID: 26332696 No abstract available.
• Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke.

  Bonvini RF, Sztajzel R, Dorsaz PA, Righini M, Bonvin C, Alibegovic J, Sigwart U, Camenzind E, Verin V, Sztajzel J. Bonvini RF, et al. Int J Stroke. 2010 Feb;5(1):4-9. doi: 10.1111/j.1747-4949.2009.00336.x. Int J Stroke. 2010. PMID: 20088986
• Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.

  Majunke N, Wallenborn J, Wunderlich N, Sievert H. Majunke N, et al. Minerva Cardioangiol. 2009 Feb;57(1):103-15. Minerva Cardioangiol. 2009. PMID: 19202522 Review.
• European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism.

  Pristipino C, Sievert H, D'Ascenzo F, Louis Mas J, Meier B, Scacciatella P, Hildick-Smith D, Gaita F, Toni D, Kyrle P, Thomson J, Derumeaux G, Onorato E, Sibbing D, Germonpré P, Berti S, Chessa M, Bedogni F, Dudek D, Hornung M, Zamorano J; Evidence Synthesis Team; Eapci Scientific Documents and Initiatives Committee; International Experts. Pristipino C, et al. Eur Heart J. 2019 Oct 7;40(38):3182-3195. doi: 10.1093/eurheartj/ehy649. Eur Heart J. 2019. PMID: 30358849 Review.